Full Press Release Details
BridgeBio To Host Investor Call To Discuss Phase 2 Cohort 5 Data For Achondroplasia.
BBIO
BridgeBio To Host Investor Call To Discuss Phase 2 Cohort 5 Data For Achondroplasia
Key Takeaway: BridgeBio To Host Investor Call To Discuss Phase 2 Cohort 5 Data For Achondroplasia
Price reaction · baseline $10.88 (2023-03-02 close) · hit after-hours · 4 other BBIO headline(s) in the window, move may be shared
day 0 close
-0.1%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+41%
120-day peak, hindsight
Typical move
3.6%
average across 13 past catalysts
Cash runway
~30 mo
Minimal dilution risk
Lead asset
acoramidis
Phase 3 · Amyloidosis